Cargando…
Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
The aim of this study was to analyze the role of Ezrin in esophageal squamous cell carcinoma (ESCC) and investigate potential therapeutic targets for ESCC by interfering with Ezrin expression. Bioinformatics analysis revealed that Ezrin expression differed significantly among patients with different...
Autores principales: | Ma, Lijuan, Liu, Li, Ji, Min, Su, Liping, Guan, Yaling, Xiao, Jinling, Pu, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543706/ https://www.ncbi.nlm.nih.gov/pubmed/37791063 http://dx.doi.org/10.1515/biol-2022-0743 |
Ejemplares similares
-
OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma
por: Liu, Li, et al.
Publicado: (2022) -
CaMKII regulates the proteins TPM1 and MYOM2 and promotes diacetylmorphine-induced abnormal cardiac rhythms
por: Ji, Min, et al.
Publicado: (2023) -
Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
por: Li, Lan, et al.
Publicado: (2017) -
Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway
por: Li, Lin, et al.
Publicado: (2023) -
Prenylated PALM2 Promotes the Migration of Esophageal Squamous Cell Carcinoma Cells Through Activating Ezrin
por: Deng, Dan-Xia, et al.
Publicado: (2023)